Athena Countouriotis

Athena Countouriotis has an estimated net worth of $19.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., IOVANCE BIOTHERAPEUTICS, INC., HALOZYME THERAPEUTICS INC, Adverum Biotechnologies, Inc., Passage BIO, Inc., Trovagene, Inc., AMBIT BIOSCIENCES CORP, and BIOMARIN PHARMACEUTICAL INC.

2021 was Athena Countouriotis's most active year for acquiring shares with 8 total transactions. Athena Countouriotis's most active month to acquire stocks was the month of January. 2021 was Athena Countouriotis's most active year for disposing of shares, totalling 17 transactions. Athena Countouriotis's most active month to dispose stocks was the month of January. 2019 saw Athena Countouriotis paying a total of $687,975.66 for 102,440 shares, this is the most they've acquired in one year. In 2022 Athena Countouriotis cashed out on 2,152,124 shares for a total of $8,540,731.30, their largest year based on trade value.